Prevention of chemotherapy medication errors

Journal of Pharmacy Practice

Volumn 15, Issue 1, 2002, Pages 17-31

  Kloth, Dwight D ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Cancer; Chemotherapy; Errors; Medication errors; Preventable; Prevention; Safety

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GENERIC DRUG; IDARUBICIN; IRINOTECAN; PACLITAXEL; VINBLASTINE; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CELL COUNT; COMPETENCE; DEMOGRAPHY; DOSE CALCULATION; DRUG INDUCED DISEASE; DRUG INFORMATION; DRUG MANUFACTURE; DRUG RESEARCH; ERROR; HOSPITAL PHARMACY; NEUTROPHIL; NOMENCLATURE; PRACTICE GUIDELINE; PRESCRIPTION; PROFESSIONAL PRACTICE; RESPONSIBILITY; RISK ASSESSMENT; RISK FACTOR; SAFETY; TREATMENT OUTCOME; UNITED STATES;

EID: 0036089203     PISSN: 08971900     EISSN: None     Source Type: Journal    
DOI: 10.1106/EXK5-5F5M-T5QV-45CW     Document Type: Article

References (78)

1. Incidence and types of adverse events and negligent care in Utah and Colorado
2. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I
3. Deaths due to medical errors are exaggerated in Institute of Medicine report
4. How many deaths are due to medical errors?
5. Institute of medicine medical error figures are not exaggerated
6. How many deaths are due to medical errors?
7. How many deaths are due to medical errors?
8. How many deaths are due to medical errors?
9. The Institute of Medicine report on medical errors
10. The Institute of Medicine report on medical errors - Could it do harm?
11. ASHP guidelines on preventing medication errors in hospitals
12. Severity-indexed, incident report-based medication error-reporting program
13. Use of severity-indexed medication error reports to improve quality
14. Systems analysis of adverse drug events
15. Incidence of adverse drug events and potential adverse drug events. Implications for prevention
16. The costs of adverse drug events in hospitalized patients
17. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality
18. Drug-related morbidity and mortality. A cost-of-illness model
19. Putting adverse drug events into perspective
20. Factors related to errors in medication prescribing
21. Assuring safe care for cancer patients through an organized multidisciplinary team effort
22. Overdose death of cancer patient rocks Mass. Hospital
23. Rx for death; cancer stricken wife of judge dies after being given the wrong medicine
24. Wrong drug killed boy
25. Recovering from medication errors: Tales of two pharmacists
26. Cancer patient in Chicago dies after chemotherapy overdose
27. Hospital admits giving wrong drug to sick child
28. "We just want justice." Parents delve into baby's cancer death
29. Punitive vs non-punitive cultures: Massachusetts regulatory boards punish health care practitioners at Dana Farber Cancer Institute
30. Medication error prevention
31. Medication error prevention
32. What is wrong with these regimens?
33. Caring enough to understand: The road to oncology medication error prevention
34. Preventing medication errors in cancer chemotherapy
35. Reducing the frequency of errors in medicine using information technology
36. Medication errors: Error No. 20. Know the patient's diagnosis before you administer the drugs
37. Medication error: Clarify laboratory test results given by telephone
38. Error 441 - Naming drug products is serious business
39. Cooperative approaches to medication error management
40. Systems that prevent error
41. Comments on ASHP guidelines for preventing medication errors
42. Failure mode and effects analysis: A novel approach to avoiding dangerous medication errors and accidents
43. Medication-error reporting. Banish a system that blames
44. Medication errors - A system problem
45. Medication errors. Cisplatin death
46. Why error reporting systems should be voluntary
47. Pain, paralysis and knowledge of impending death marks intrathecal vincristine
48. What should a pharmacy manager do when a serious medication error occurs? A panel discussion
49. Medication error prevention: Profiling one of pharmacy's foremost advocacy efforts for advice on error prevention
50. Orientation teaching tool to prevent medication error
51. Standardizing the expression and nomenclature of cancer treatment regimens
52. Inadvertent intrathecal injection of daunorubicin with fatal outcome
53. Severe acute encephalopathy following inadvertent intrathecal doxorubicin administration
54. Error in medication
55. The preparation of vincristine in minibags will prevent deadly medication errors
56. The stability of diluted vincristine sulfate used as a deterrent to inadvertent intrathecal injection
57. Cerebrospinal fluid lavage in the treatment of inadvertent intrathecal vincristine injection
58. Intrathecal vincristine: A fatal chemotherapeutic error with devastating central nervous system effects
59. Prolonged survival following the inadvertent intrathecal administration of vincristine: Clinical and electrophysiologic analyses
60. Treatment of inadvertent intrathecal injection of vincristine
61. Intrathecal vincristine: An analysis of reasons for recurrent fatal chemotherapeutic error with recommendations for prevention
62. Intrathecal vincristine. Report of a fatal case despite CNS washout
63. Neural toxicity induced by accidental intrathecal vincristine administration
64. Accidental intrathecal vincristine administration. Report of a case
65. Potential salvage therapy for inadvertent intrathecal administration of vincristine
66. Potential salvage therapy for accidental intrathecal vincristine administration: A preliminary experimental study
67. Neuronal changes induced by intrathecal vincristine sulfate
68. Accidental intrathecal administration of vincristine
69. Fatal myeloencephalopathy caused by intrathecal vincristine
70. Ascending myeloencephalopathy due to intrathecal vincristine sulfate. A fatal chemotherapeutic error
71. Neurourologic consequences of accidental intrathecal vincristine: A case report
72. Irinotecan overdoses